331. 特発性多中心性キャッスルマン病 Idiopathic multicentric castleman disease Clinical trials / Disease details

臨床試験数 : 33 / 薬物数 : 46 - (DrugBank : 25) / 標的遺伝子数 : 31 - 標的パスウェイ数 : 155

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR2100048364	2021-09-01	2021-07-06	A single-arm, prospective, and multicenter study of rituximab combined with lenalidomidein Castleman ...	A single-arm, prospective, and multicenter study of rituximab combined with lenalidomidein Castleman ...	Castleman disease	Treatment group:Rituximab+lenalidomide;	Department of Hematology, Jiangsu Provincial People's Hospital	NULL	Pending	14	90	Both	Treatment group:20;	Phase 4	China

First Previous1Next Last